Serum Vitamin D Status and Outcome among Critically Ill Children Admitted to the Pediatric Intensive Care Unit in

Kala Ebenezer1, Victoria Job2, Belavendra Antonisamy3

  • 1Department of Pediatrics, Christian Medical College, Vellore, 632004, Tamil Nadu, India. kinbaraj@cmcvellore.ac.in.

Insights

Vitamin D deficiency is prevalent in critically ill children in South India, affecting 40.3%. Low vitamin D levels correlate with increased illness severity and need for mechanical ventilation, but not mortality.

Area of Science:

  • Pediatric Intensive Care
  • Nutritional Deficiency
  • Clinical Outcomes

Background:

  • Vitamin D status is crucial for pediatric health.
  • Critically ill children may have altered vitamin D metabolism.
  • Understanding vitamin D's role in pediatric intensive care is important.

Purpose of the Study:

  • To assess vitamin D status in critically ill South Indian children.
  • To investigate the association between vitamin D levels and clinical outcomes in the pediatric intensive care unit (PICU).

Main Methods:

  • Serum 25(OH)D levels were measured in 54 critically ill children.
  • Illness severity was assessed using PIM-2 and CV-SOFA scores.
  • Vitamin D deficiency was defined as <20 ng/ml.

Main Results:

  • 40.3% of children exhibited vitamin D deficiency.
  • Lower vitamin D levels were linked to higher illness severity scores (PIM-2, SOFA).
  • Mechanically ventilated children had significantly lower vitamin D levels.

Conclusions:

  • Vitamin D deficiency is common in South Indian pediatric ICU patients.
  • Low vitamin D is associated with greater illness severity and ventilation needs.
  • No significant association was found between vitamin D status and mortality.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
504
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.5K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
817
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
484
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
762